Promis Neurosciences Inc (PMN)

Nov 20, 2024

ProMIS Neurosciences stock hits 52-week low at $0.91 - Investing.com

Nov 20, 2024

Nov 20, 2024

ProMIS Neurosciences stock hits 52-week low at $0.91 By Investing.com - Investing.com Australia

Nov 20, 2024

Nov 16, 2024

ProMIS Neurosciences Announces Third Quarter Financial Results and Recent HighlightsOn November 14, 2024, ProMIS Neurosciences Inc. (Nasdaq: PMN) shared its financial outcomes for the third quarter ended September 30, 2024. The company provide - Defense World

Nov 16, 2024

Nov 15, 2024

ProMIS Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024

Nov 15, 2024

GREAT POINT PARTNERS LLC Acquires Shares in ProMIS Neurosciences Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

ProMIS Neurosciences Inc (PMN) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in ProMIS Neurosciences Inc - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

ProMIS Neurosciences Inc Reports Q3 2024 GAAP EPS of $0.31, Surp - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

ProMIS Reports Positive Phase 1a Results for Alzheimer's Drug, Secures $30.3M Financing | PMN Stock News - StockTitan

Nov 14, 2024

Nov 12, 2024

ProMIS Neurosciences to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference - GlobeNewswire

Nov 12, 2024

Nov 06, 2024

ProMIS Neurosciences (STU:23J0) PensionAndRetirementBenefit : €0.43 Mil (As of Jun. 2024) - GuruFocus.com

Nov 06, 2024

Oct 31, 2024

Biotech Shares Positive Phase I Data for Alzheimer's Treatment - Streetwise Reports

Oct 31, 2024

Oct 30, 2024

ProMIS Neurosciences Presents Positive Data from PMN310 - GlobeNewswire

Oct 30, 2024

Oct 30, 2024

ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference - StockTitan

Oct 30, 2024

Oct 24, 2024

ProMIS Neurosciences, Inc. (NASDAQ:PMN): Among The 10 Oversold Canadian Stocks to Buy Right Now - Insider Monkey

Oct 24, 2024

Oct 22, 2024

ProMIS Neurosciences stock hits 52-week low at $0.92 - Investing.com India

Oct 22, 2024

Oct 21, 2024

ProMIS Neurosciences stock hits 52-week low at $0.92 By Investing.com - Investing.com South Africa

Oct 21, 2024

Oct 13, 2024

ProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock Now - Insider Monkey

Oct 13, 2024

Oct 11, 2024

ProMIS Neurosciences appoints new CEO Neil Warma By Investing.com - Investing.com Australia

Oct 11, 2024

Oct 10, 2024

ProMIS Neurosciences appoints new CEO Neil Warma - Investing.com

Oct 10, 2024

Oct 10, 2024

ProMIS Neurosciences Names Neil Warma Permanent CEO - TipRanks

Oct 10, 2024

Sep 29, 2024

ProMIS Neurosciences (NASDAQ:PMN) versus Rigel Pharmaceuticals (NASDAQ:RIGL) Head-To-Head Analysis - Defense World

Sep 29, 2024

Sep 25, 2024

ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying - MSN

Sep 25, 2024

Sep 25, 2024

Director Madge Shafmaster Acquires 200,000 Shares of ProMIS Neur - GuruFocus.com

Sep 25, 2024

Sep 24, 2024

ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Madge K. Shafmaster Acquires 60,000 Shares - Defense World

Sep 24, 2024

Sep 24, 2024

ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Buys $89,600.00 in Stock - Defense World

Sep 24, 2024

Sep 24, 2024

ProMIS Neurosciences director Shafmaster purchases $255,750 in stock By Investing.com - Investing.com South Africa

Sep 24, 2024

Sep 24, 2024

ProMIS Neurosciences director Shafmaster purchases $255,750 in stock - Investing.com India

Sep 24, 2024

Sep 24, 2024

ProMIS Neurosciences (NASDAQ:PMN) versus Regulus Therapeutics (NASDAQ:RGLS) Critical Contrast - Defense World

Sep 24, 2024

Sep 24, 2024

BSE SME Popular Foundation slips on debut - Business Standard

Sep 24, 2024

Sep 24, 2024

Popular Foundations shares list at IPO price on BSE SME platform - The Economic Times

Sep 24, 2024

Sep 24, 2024

Popular Foundations makes tepid debut, shares list flat at ₹37 apiece on BSE SME platform - Upstox

Sep 24, 2024

Sep 19, 2024

How To Check Popular Foundations IPO Allotment Status - NDTV Profit

Sep 19, 2024

Sep 19, 2024

Taking a look at what insiders are doing to gauge the PureCycle Technologies Inc (PCT)’s direction - Knox Daily

Sep 19, 2024

Sep 19, 2024

Popular Foundations IPO allotment to be finalized today - IPO Watch

Sep 19, 2024

Sep 19, 2024

Prosperity Bancshares, Inc. (NYSE:PB) Shares Bought by Federated Hermes Inc. - Defense World

Sep 19, 2024

Sep 18, 2024

The Psychology of PureCycle Technologies Inc Inc. (PCT) Price Performance: Understanding Market Sentiment - The InvestChronicle

Sep 18, 2024

Sep 13, 2024

ProMIS Neurosciences to Showcase PMN310’s Ability to Target - GlobeNewswire

Sep 13, 2024

Sep 12, 2024

ProMIS unveils promising Alzheimer's antibody data at ICBN By Investing.com - Investing.com Australia

Sep 12, 2024

Sep 12, 2024

ProMIS unveils promising Alzheimer's antibody data at ICBN - Investing.com India

Sep 12, 2024

Sep 12, 2024

Pre-market Movers: TNON, FULC, SMFL, RYDE, NTGR… - RTTNews

Sep 12, 2024

Sep 07, 2024

ProMIS Neurosciences (NASDAQ:PMN) Trading Down 5% - Defense World

Sep 07, 2024